Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.

Annals of surgical oncology·2016
Same author

Exclusion criteria for assuring safety of single-incision laparoscopic cholecystectomy.

Bioscience trends·2016
Same author

Advantages and Disadvantages of Prophylactic Abdominal Drainage in Distal Pancreatectomy.

World journal of surgery·2016
Same author

Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

World journal of gastroenterology·2016
Same author

Recurrent Acute Liver Failure Because of Acute Hepatitis Induced by Organic Solvents: A Case Report.

Medicine·2016
Same author

Clinicopathologic Characteristics of Hepatocellular Carcinoma With Reactive Ductule-like Components, a Subset of Liver Cancer Currently Classified as Combined Hepatocellular-Cholangiocarcinoma With Stem-Cell Features, Typical Subtype.

The American journal of surgical pathology·2016

Related Experiment Video

Updated: Jun 20, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

[Hepatocellular carcinoma].

Yoshifumi Beck1, Norihiro Kokudo

  • 1Hepato-Biliary-Pancreatic Surgery Division, Dept. of Surgery, Tokyo University Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 17, 2009
PubMed
Summary

Regular monitoring with tumor markers and imaging is crucial for two years post-hepatectomy for hepatocellular carcinoma. Early detection of recurrence via dynamic CT, followed by anatomic liver resection, improves patient survival.

Area of Science:

  • Hepatobiliary surgery
  • Oncology
  • Medical imaging

Background:

  • Hepatocellular carcinoma (HCC) is a primary liver cancer.
  • Hepatectomy is a common surgical treatment for HCC.
  • Post-operative surveillance is essential for managing HCC recurrence.

Observation:

  • Monthly monitoring using tumor markers (alpha-fetoprotein/AFP, protein induced by vitamin K absence-II/PIVKA-II, AFP lectin-binding subtype L3/AFP-L3) and abdominal ultrasound is recommended.
  • Dynamic computed tomography (CT) scans every 4-6 months for two years are vital for detecting recurrence.
  • Recurrent HCC detected by dynamic CT necessitates prompt intervention.

Findings:

  • Early detection of recurrent HCC through regular surveillance improves treatment outcomes.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jun 20, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining
07:43

Laparoscopic S7 Hepatectomy with Positive Fluorescence Staining

Published on: May 9, 2025

  • Anatomic liver resection is the preferred surgical approach for recurrent HCC.
  • Adherence to recommended follow-up protocols enhances survival rates for HCC patients post-hepatectomy.
  • Implications:

    • Establishes a clear follow-up protocol for post-hepatectomy HCC patients.
    • Highlights the importance of dynamic CT in identifying recurrent disease.
    • Emphasizes the survival benefit of timely anatomic liver resection for HCC recurrence.